FDA Approves Belimumab Autoinjector for Pediatric Lupus

The US Food and Drug Administration (FDA) has approved Benlysta (belimumab) autoinjector for patients aged 5 years or older with active systemic lupus erythematosus (SLE) on standard therapy. This is the first time that children with SLE can receive this treatment at home, according to a GSK press release…

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button